Journal of Gastroenterology
Fecha de publicación: 13 July 2020
Autores: Nakase, H., Matsumoto, T., Watanabe, K. et al.
Background: Gastrointestinal (GI) cancers are among the most common and lethal solid tumors worldwide. Unlike in malignancies such as lung, renal and skin cancers, the activity of immunotherapeutic agents in GI cancers has, on the whole, been much less remarkable and do not apply to the majority.Leer más